XSHE
300371
Market cap303mUSD
Oct 09, Last price
10.02CNY
1D
-0.69%
1Q
0.91%
Jan 2017
-57.14%
IPO
-29.98%
Name
Huizhong Instrumentation Co Ltd
Chart & performance
P/E
30.45
P/S
4.48
EPS
0.33
Div yield, %
0.88%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
-2.96%
Revenues
450m
+16.79%
Net income
66m
+14.70%
CFO
156m
+87.02%
Dividend
Jun 09, 20260.1 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Huizhong Instrumentation Co., Ltd. is a Chinese enterprise that specializes in the research, development, production, and distribution of ultrasonic heat, water, and flow meters. Its water metering products are designed for diverse applications, including residential water supply, comprehensive water management systems, modeling, and precise billing. Likewise, its heat meters are utilized in residential settings, public and commercial buildings, for temperature regulation, and for accurate invoicing. Established in 1994, the company was initially known as Tangshan Huizhong Instrumentation Co., Ltd. before officially adopting its current name in September 2015. Its operations are headquartered in Tangshan, China.
Key people
Lixin Zhang
Chairman of the Board · since 2019
Hui Chen
Director, Chief Engineer · since 2019
Guoxing Liu
Director - Software R&D Department · since 2020
Di Wan
Director-Operations Management Department · since 2025
Dapeng Feng
Director, Secretary of the Board · since 2019
Junjie Li
Secretary of the Board · since 2025
Lizhi Guo
Deputy General Manager, Director, Director-Intelligent Manufacturing Department · since 2025
Jinghui Qiu
Director · since 2025
Jian Wang
Director · since 2019
Jichuan Zhang
Director · since 2019
Independent Director · since 2019
Fuqiang Wang
Independent Director · since 2025
Ying Wang
Independent Director · since 2019
Fan Wu
Independent Director · since 2025
Suxiang Zhang
Independent Director · since 2019
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||